Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou Gehrigs Disease”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableNo Longer AvailableNCT06069934
What this trial is testing

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Who this might be right for
Amyotrophic Lateral Sclerosis
Prilenia
Testing effectiveness (Phase 2)Study completedNCT00647296
What this trial is testing

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 194
Testing effectiveness (Phase 2)Looking for participantsNCT06527222
What this trial is testing

Ranolazine in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Swathy Chandrashekhar, MBBS 72
Large-scale testing (Phase 3)Ended earlyNCT00818389
What this trial is testing

Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 84
Not applicableWithdrawnNCT01459302
What this trial is testing

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPLS+7 more
University of Massachusetts, Worcester
Large-scale testing (Phase 3)Study completedNCT05136885
What this trial is testing

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Large-scale testing (Phase 3)Study completedNCT05740813
What this trial is testing

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 310
Testing effectiveness (Phase 2)Study completedNCT02469896
What this trial is testing

A Trial of Tocilizumab in ALS Subjects

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig's Disease+1 more
Barrow Neurological Institute 22
Testing effectiveness (Phase 2)Study completedNCT00748501
What this trial is testing

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Sangamo Therapeutics 45
Testing effectiveness (Phase 2)Study completedNCT00931944
What this trial is testing

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 74
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT04414345
What this trial is testing

HEALEY ALS Platform Trial - Regimen C CNM-Au8

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Testing effectiveness (Phase 2)Looking for participantsNCT07142291
What this trial is testing

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
PhenoNet, Inc. 105
Not applicableLooking for participantsNCT05067179
What this trial is testing

Analysis of Human ALS Tissues and Registry of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Illinois at Chicago 40
Testing effectiveness (Phase 2)Study completedNCT00790582
What this trial is testing

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Forbes Norris MDA/ALS Research Center 109
Testing effectiveness (Phase 2)Study completedNCT00956488
What this trial is testing

Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseLou Gehrig's Disease
Wake Forest University Health Sciences 9
Post-approval studies (Phase 4)Study completedNCT01811355
What this trial is testing

Mexiletine for the Treatment of Muscle Cramps in ALS

Who this might be right for
Muscle Cramps in Amyotrophic Lateral Sclerosis
Bjorn Oskarsson, MD 23
Large-scale testing (Phase 3)Study completedNCT01281189
What this trial is testing

Phase 3 Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 942
Testing effectiveness (Phase 2)Ended earlyNCT04428775
What this trial is testing

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Who this might be right for
Amyotrophic Lateral Sclerosis
AZTherapies, Inc. 12
Testing effectiveness (Phase 2)WithdrawnNCT00561366
What this trial is testing

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
CytRx
Load More Results